John D. Quisel - 18 Feb 2025 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: IRON
Reported as of: 18 Feb 2025
Net transaction value: -$304,229
SEC form: 4
Accepted by SEC: 20 Feb 2025, 19:27:58 UTC
Prior SEC filing: 12 Feb 2025
Next SEC filing: 08 Apr 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Rahul Khara, as Attorney-in-Fact

Key filing fact

John D. Quisel filed Form 4 for Disc Medicine, Inc. (IRON) on 20 Feb 2025.

Key facts

This page summarizes John D. Quisel's Form 4 filing for Disc Medicine, Inc. (IRON).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Feb 2025, 19:27.

Change

Previous filing in this sequence was filed on 12 Feb 2025.
Current net transaction value: -$304,229.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRON transaction

Common Stock

Sale

Transaction value: $304,229
Shares: -5,574
Change %: -3.5%
Price: $54.58
Shares after: 154,828
Date: 18 Feb 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units granted on January 10, 2024 and previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.